Explore our standard-setting research and commercial active pharmaceutical ingredients available for global contract manufacturing.
Understanding the molecular integrity, peptide sequence chemistry, and lyophilization stability of Growth Hormone Releasing Hexapeptide.
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. Designed specifically to stimulate the endogenous secretion of growth hormone via the Growth Hormone Secretagogue Receptor (GHS-R1a), GHRP-6 features unnatural D-amino acids (D-Trp and D-Phe) that confer high enzymatic stability against systemic peptidases.
Our OEM GHRP-6 5mg vials are manufactured using automated Solid-Phase Peptide Synthesis (SPPS), ensuring exact sequence fidelity, complete trifluoroacetic acid (TFA) salt removal or conversion to acetate, and ultra-low endotoxin levels suitable for rigorous scientific and commercial formulation applications.
The standard OEM format—GHRP-6 5mg per vial—requires precise freeze-drying (lyophilization) protocols to achieve a stable, uniform cake structure. Gentolex utilizes cleanroom Grade A (Class 100) automated lyophilization bays to ensure moisture content remains strictly below 3.0%.
| Parameter | Gentolex OEM Standard Specification | Analytical Method |
|---|---|---|
| Chemical Sequence | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | Edman Degradation / MS-MS |
| Molecular Formula & Weight | C46H56N12O6 | 873.01 g/mol | Mass Spectrometry (ESI-MS) |
| Purity (HPLC) | ≥ 99.0% (Custom high-purity batching available) | Reverse-Phase High Performance Liquid Chromatography |
| Counter Ion | Acetate (Standard) or Trifluoroacetate (TFA) | Ion Chromatography |
| Bacterial Endotoxins | < 0.05 EU/mg | LAL Kinetic Chromogenic Method |
| Water Content (Karl Fischer) | ≤ 3.0% | Karl Fischer Titration |
| Reconstitution Time | < 30 seconds in Sterile Water for Injection | Visual Clarity Assessment |
Integrated peptide API production, finished product packaging, custom laboratory setups, and licensing solutions for global brands.
Our overall factory construction area of 250,000 square meters operates under international cGMP, ISO 9001, and ISO 13485 standards. We provide flexible, scalable, and cost-effective solutions ranging from milligram-scale research batches to multi-kilogram commercial peptide production.
We offer full white-label and private-label contract packaging for GHRP-6 5mg. Services include customized primary vial glass selection, anti-counterfeiting holographic labeling, custom flip-off cap laser etching, custom box design, and cold-chain blister packing.
Gentolex delivers Finished Dosage Form (FDF) license out services along with complete technical documentation support, including Drug Master Files (DMF), Certificate of Analysis (CoA), MS, HPLC chromatograms, NMR structure verification, and stability testing reports.
Delivering peptide excellence through robust infrastructure and international compliance hub networks.
Why multinational bio-tech enterprises partner with Gentolex for scale, quality consistency, and cost effectiveness.
The manufacturing efficiency of peptides like GHRP-6 relies heavily on the steady supply of high-grade protected amino acids (Fmoc/Boc chemistry) and coupling reagents (HATU, HBTU, DIC). China possesses the world's most complete chemical synthesis infrastructure.
At Gentolex, we maintain full backward integration into basic chemical precursors, securing consistent raw material purity while immunizing contract procurement partners from global supply chain volatility and price spikes.
Operating state-of-the-art multi-channel automated synthesizers coupled with high-capacity preparative HPLC purification columns allows Gentolex to achieve unprecedented economies of scale.
Enterprise clients purchasing OEM GHRP-6 5mg benefit from significantly reduced per-unit costs without compromising analytical rigors or regulatory compliance required for market entry.
For enterprise clients seeking to avoid the logistical friction of managing multiple raw material vendors, container suppliers, label printers, and testing labs, Gentolex offers an all-inclusive customized procurement platform. We manage end-to-end operations from preliminary peptide synthesis to customs brokerage and localized door-to-door delivery.
Navigating global regulatory landscapes with dedicated regional presence in key international markets.
To provide seamless localized client support, Gentolex Group has established active regional operating entities and representatives in Mexico (covering LATAM) and South Africa (covering the EMEA region). Up to date, Gentolex serves enterprise clients across more than 10 countries worldwide.
These local hubs ensure real-time technical consultation, local currency invoicing capability, streamlined import clearance, and localized cold-chain warehouse distribution.
Every commercial lot of OEM GHRP-6 5mg undergoes comprehensive analytical validation prior to release. Our Quality Assurance (QA) release dossier includes:
Analyzing key scientific research fields and market directions shaping peptide contract manufacturing.
GHRP-6 is extensively used in preclinical models investigating ghrelin receptor (GHS-R1a) signaling, pituitary growth hormone release dynamics, and hypothalamic regulation of appetite and metabolic homeostasis.
Beyond endocrine pathways, scientific literature highlights GHRP-6 in cellular protection, ischemia-reperfusion injury mitigation, myocardial protection, and wound healing signaling cascades.
In veterinary biopharmaceuticals, GHRP-6 formulations are evaluated for growth stimulation, muscle mass retention, and metabolic recovery in agricultural livestock and veterinary models.
The global peptide CDMO/OEM industry is undergoing a paradigm shift toward sustainable green synthesis and advanced drug delivery mechanisms. Gentolex leads this evolution by integrating eco-friendly synthesis solvents (such as Cyrene and green polar solvents) to replace traditional DMF, reducing hazardous waste output by over 40%.
Furthermore, demand for convenient dosage formats is rising. Gentolex supports next-generation packaging options, including Dual-Chamber Cartridge systems that keep lyophilized GHRP-6 powder and diluent separated in a single unit for instant, sterile reconstitution prior to administration.
Explore our extensive portfolio of neuroactive, metabolic, and tissue-regenerative active pharmaceutical ingredients.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a synthetic derivative of human tuftsin...
View Details
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, research organizations, and pharmaceutical formulation facilities worldwide...
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis, and inflammatory regulation...
View Details
With continuous developments in neuroscience and life science research, neuroactive peptides have become a crucial focal point. Semax, derived from an ACTH fragment, is manufactured at scale with rigorous purity benchmarks...
View Details
SS-31 API, also known as Elamipretide, MTP-131, or Bendavia, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, supporting bioenergetics and cellular stability...
View DetailsOur core offerings center on supplying peptide APIs, custom sequence synthesis, FDF licensing, lab setup consultation, and robust end-to-end supply chain integration.
Contact Engineering Team
Essential technical and commercial insights for enterprise buyers, distributors, and formulation labs.
Browse our expanded portfolio of therapeutic peptides, APIs, and specialty chemical intermediates.
